香港医思医疗集团(02138.HK)拟配售最多2963.6万股 净筹2.3亿港元
格隆汇 4 月 19日丨香港医思医疗集团(02138.HK)发布公告,2021年4月16日,公司与配售代理(即海通国际)订立配售协议,据此,公司有条件同意透过配售代理按尽力基准以每股配售股份7.80港元的价格向承配人配售最多合共2963.6万股配售股份。
预期配售股份将配售予郑志刚(以个人名义投资)及Aspex Master Fund。承配人(即郑志刚)为一名文化企业家及一名个人投资者,而Aspex为一间于开曼群岛注册成立的获豁免有限公司,以私人投资基金形式营运。Aspex Management (HK) Limited为一间于香港成立的持牌法团,可根据证券及期货条例于香港从事第9类(资产管理)受规管活动,并担任Aspex的投资经理。
可予配发及发行的配售股份将动用一般授权,并将占公司于本公告日期现有已发行股本的2.77%及经扩大已发行股本的约2.69%。配售价每股7.80港元较4月16日(即配售协议日期)在联交所所报的收市价每股股份7.68港元溢价约1.56%。
假设配售代理成功配售所有配售股份,配售事项的估计所得款项总额及所得款项净额将分别约为2.312亿港元及2.31亿港元。净配售价估计约为每股配售股份7.79港元。公司拟将配售事项所得款项净额用于扩大集团于中国香港及中国大湾区的诊所网络、并购及集团的一般企业用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.